{"document_type": "article", "byline": {"contributor": "", "person": [], "organization": "REUTERS", "original": "By REUTERS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Food and Drug Administration approves hepatitis C drug Zepatier made by Merck; price is $54,600 for 12-week regimen.", "multimedia": [], "headline": {"print_headline": "Merck Hepatitis Drug Approved", "main": "Hepatitis C Drug From Merck Is Approved"}, "print_page": "8", "keywords": [{"value": "Merck & Company Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Hepatitis", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "4", "name": "subject"}], "snippet": "American regulators approved a new once-daily pill for the liver-destroying virus made by Merck, which said it would sell the drug at a lower list price than its competitors.", "source": "The New York Times", "lead_paragraph": "American regulators approved a new once-daily pill for the liver-destroying virus made by Merck, which said it would sell the drug at a lower list price than its competitors.", "word_count": "237", "pub_date": "2016-01-29T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/01/29/business/hepatitis-c-drug-from-merck-is-approved.html", "_id": "56abab5638f0d87a41957476"}